|Last Price$114.13||Day Change (%)-0.70%|
|Open Price$115.80||Day Change ($)-0.81|
|Day Range112.20–116.78||52-Week Range110.56–208.88|
As of Wed 6/29/2016 4:59:00 PM | USD
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against Alexion Pharmaceuticals , Inc. And Advises Investors With Losses To Contact The Firm
Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA® (pembrolizumab) for the Treatment of Multiple Types of Cancer
Biogen Shares Down as Multiple Sclerosis Therapy Misses Study Goals -- Update
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Ownership data provide a look at who else owns the company.
Standing out in a good year for stocks.
Buying a country or sector fund isn't as easy as it seems.
Week ending Nov. 10: Investors remain optimistic about direction of economy.